Ruth H Strasser

Author PubWeight™ 86.20‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Levosimendan is superior to enoximone in refractory cardiogenic shock complicating acute myocardial infarction. Crit Care Med 2008 3.50
2 Routine upstream initiation vs deferred selective use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: the ACUITY Timing trial. JAMA 2007 3.07
3 Transcatheter closure of patent foramen ovale in patients with cerebral ischemia. J Am Coll Cardiol 2002 2.24
4 Intraaortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock: design and rationale of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial. Am Heart J 2012 1.65
5 Impedance cardiography as a noninvasive technique for atrioventricular interval optimization in cardiac resynchronization therapy. J Interv Card Electrophysiol 2005 1.60
6 Perforation of aortic root as secondary complication after implantation of patent foramen ovale occlusion device in a 31-year-old woman. J Interv Cardiol 2006 1.60
7 Caveolin-1 facilitates mechanosensitive protein kinase B (Akt) signaling in vitro and in vivo. Circ Res 2005 1.55
8 Regulation of protein kinase C isozyme and calcineurin expression in isoproterenol induced cardiac hypertrophy. J Cardiovasc Pharmacol 2003 1.49
9 [Position document on quality assurance in invasive cardiology. Are minimum numbers in percutaneous coronary angioplasty evidence based?]. Z Kardiol 2004 1.49
10 Transient global amnesia and broken heart syndrome: two faces of one pathology. Clin Auton Res 2015 1.40
11 Nomograms for severity of aortic valve stenosis using peak aortic valve pressure gradient and left ventricular ejection fraction. Eur J Echocardiogr 2009 1.39
12 Effects of the Peroxisome Proliferator-Activated Receptor-γ Agonist Pioglitazone on Peripheral Vessel Function and Clinical Parameters in Nondiabetic Patients: A Double-Center, Randomized Controlled Pilot Trial. Cardiology 2015 1.39
13 Single coronary artery with anomalous origin from the right sinus Valsalva. Clin Res Cardiol 2006 1.35
14 Caveolae and caveolin in transmembrane signaling: Implications for human disease. Cardiovasc Res 2006 1.25
15 Generation of mature murine monocytes from heterogeneous bone marrow and description of their properties. J Histochem Cytochem 2011 1.18
16 Protein kinase C in the human heart: differential regulation of the isoforms in aortic stenosis or dilated cardiomyopathy. Mol Cell Biochem 2007 1.17
17 Disruption of caveolin-1 leads to enhanced nitrosative stress and severe systolic and diastolic heart failure. Biochem Biophys Res Commun 2005 1.14
18 Remote preconditioning by infrarenal occlusion of the aorta protects the heart from infarction: a newly identified non-neuronal but PKC-dependent pathway. Cardiovasc Res 2002 1.10
19 The adverse cardiopulmonary phenotype of caveolin-1 deficient mice is mediated by a dysfunctional endothelium. J Mol Cell Cardiol 2008 1.08
20 Differential phosphorylation-dependent regulation of constitutively active and muscarinic receptor-activated IK,ACh channels in patients with chronic atrial fibrillation. Cardiovasc Res 2007 1.06
21 Remote preconditioning by infrarenal aortic occlusion is operative via delta1-opioid receptors and free radicals in vivo in the rat heart. Cardiovasc Res 2004 1.04
22 Decreased caveolin-1 in atheroma: loss of antiproliferative control of vascular smooth muscle cells in atherosclerosis. Cardiovasc Res 2005 1.02
23 Chronic NOS inhibition prevents adverse lung remodeling and pulmonary arterial hypertension in caveolin-1 knockout mice. Pulm Pharmacol Ther 2007 1.02
24 The expression of macrophage migration inhibitory factor 1alpha (MIF 1alpha) in human atherosclerotic plaques is induced by different proatherogenic stimuli and associated with plaque instability. Atherosclerosis 2005 1.00
25 Broken heart syndrome: Tako Tsubo cardiomyopathy associated with an overdose of the serotonin-norepinephrine reuptake inhibitor Venlafaxine. Eur Neuropsychopharmacol 2010 0.95
26 Cardioprotection by postconditioning is lost in WOKW rats with metabolic syndrome: role of glycogen synthase kinase 3beta. J Cardiovasc Pharmacol 2008 0.95
27 Restrictive cardiomyopathy in a patient with primary hyperoxaluria type II. Clin Res Cardiol 2006 0.94
28 Transcriptional regulation of Pim-1 kinase in vascular smooth muscle cells and its role for proliferation. Basic Res Cardiol 2009 0.93
29 Transcriptional activation of DNA-dependent protein kinase catalytic subunit gene expression by oestrogen receptor-alpha. EMBO Rep 2010 0.93
30 Right ventricular hypertrophy and apoptosis after pulmonary artery banding: regulation of PKC isozymes. Cardiovasc Res 2003 0.93
31 Postconditioning with levosimendan reduces the infarct size involving the PI3K pathway and KATP-channel activation but is independent of PDE-III inhibition. Basic Res Cardiol 2009 0.91
32 Phenotypic overlap between hematopoietic cells with suggested angioblastic potential and vascular endothelial cells. J Hematother Stem Cell Res 2002 0.91
33 Use of oral endothelin-receptor antagonist bosentan in the treatment of portopulmonary hypertension. Transplantation 2004 0.91
34 Phenotypic overlap between monocytes and vascular endothelial cells. Adv Exp Med Biol 2003 0.90
35 Correlation of heart-type fatty acid-binding protein with mortality and echocardiographic data in patients with pulmonary embolism at intermediate risk. Am Heart J 2010 0.89
36 Prone positioning in the acute respiratory distress syndrome. N Engl J Med 2013 0.88
37 Cell-specific and hypoxia-dependent regulation of human HIF-3α: inhibition of the expression of HIF target genes in vascular cells. Cell Mol Life Sci 2010 0.88
38 Regulation of protein kinase C isozymes in volume overload cardiac hypertrophy. Mol Cell Biochem 2004 0.87
39 Percutaneous lead implantation connected to an external device in stimulation-dependent patients with systemic infection--a prospective and controlled study. Pacing Clin Electrophysiol 2006 0.87
40 Images in clinical medicine. Uni-, bi-, tri-, and quadricuspid aortic valves. N Engl J Med 2006 0.86
41 Isolation and transduction of monocytes: promising vehicles for therapeutic arteriogenesis. Langenbecks Arch Surg 2006 0.86
42 Apoptosis at a distance: remote activation of caspase-3 occurs early after myocardial infarction. Mol Cell Biochem 2006 0.86
43 Interatrial septal closure devices and aortic perforation: a note of caution. J Invasive Cardiol 2009 0.86
44 Nitric oxide synthases are crucially involved in the development of the severe cardiomyopathy of caveolin-1 knockout mice. Biochem Biophys Res Commun 2008 0.85
45 The iron-regulatory peptide hepcidin is upregulated in the ischemic and in the remote myocardium after myocardial infarction. Peptides 2010 0.84
46 Twiddler's syndrome in an adolescent patient with ICD during neurological and physical rehabilitation. Clin Res Cardiol 2008 0.84
47 Differential regulation of cardiac protein kinase C isozyme expression after aortic banding in rat. Cardiovasc Res 2002 0.84
48 Regulation of the HIF-system in human macrophages--differential regulation of HIF-α subunits under sustained hypoxia. Mol Immunol 2013 0.83
49 Ischemic post-conditioning reduces infarct size of the in vivo rat heart: role of PI3-K, mTOR, GSK-3beta, and apoptosis. Mol Cell Biochem 2010 0.83
50 Transplantation of bone marrow derived monocytes: a novel approach for augmentation of arteriogenesis in a murine model of femoral artery ligation. Am J Transl Res 2013 0.83
51 Images in cardiovascular medicine. Aortic endocarditis caused by inadvertent left ventricular pacemaker lead placement. Circulation 2005 0.83
52 Regulation of the Hif-system by micro-RNA 17 and 20a - role during monocyte-to-macrophage differentiation. Mol Immunol 2013 0.82
53 Indocyanine green angiography: a new method to quantify collateral flow in mice. J Vasc Surg 2008 0.82
54 Chronic angiotensin II receptor blockade induces cardioprotection during ischemia by increased PKC-epsilon expression in the mouse heart. J Cardiovasc Pharmacol 2007 0.82
55 Ischemic preconditioning promotes a transient, but not sustained translocation of protein kinase C and sensitization of adenylyl cyclase. Basic Res Cardiol 2003 0.82
56 Functional, morphologic, and molecular characterization of cold storage injury. J Vasc Surg 2012 0.81
57 Meta-analysis of heart valve abnormalities in Parkinson's disease patients treated with dopamine agonists. Mov Disord 2007 0.81
58 Impact of Hey2 and COUP-TFII on genes involved in arteriovenous differentiation in primary human arterial and venous endothelial cells. Basic Res Cardiol 2013 0.81
59 Results of angioplasty (with or without stent) at the site of a narrowed coronary anastomosis of the left internal mammary artery graft or via the internal mammary artery. Am J Cardiol 2004 0.81
60 Ephrin-A1/EphA4-mediated adhesion of monocytes to endothelial cells. Biochim Biophys Acta 2013 0.81
61 Cardioprotection by ischemic postconditioning is abrogated in hypertrophied myocardium of spontaneously hypertensive rats. J Cardiovasc Pharmacol 2013 0.81
62 Fluorochrome-based definition of naturally occurring Foxp3(+) regulatory T cells of intra- and extrathymic origin. Eur J Immunol 2014 0.81
63 OxLDL and macrophage survival: essential and oxygen-independent involvement of the Hif-pathway. Basic Res Cardiol 2011 0.80
64 MiR-134-mediated β1 integrin expression and function in mesenchymal stem cells. Biochim Biophys Acta 2013 0.80
65 Effects of the PPARγ agonist pioglitazone on coronary atherosclerotic plaque composition and plaque progression in non-diabetic patients: a double-center, randomized controlled VH-IVUS pilot-trial. Heart Vessels 2014 0.79
66 Uncoupled eNOS annihilates neuregulin-1β-induced cardioprotection: a novel mechanism in pharmacological postconditioning in myocardial infarction. Mol Cell Biochem 2012 0.79
67 The lysosomal transfer of LDL/cholesterol from macrophages into vascular smooth muscle cells induces their phenotypic alteration. Cardiovasc Res 2012 0.79
68 Dexrazoxane prevents the development of the impaired cardiac phenotype in caveolin-1-disrupted mice. J Cardiovasc Pharmacol 2013 0.79
69 Tetanus toxoid-pulsed monocyte vaccination for augmentation of collateral vessel growth. J Am Heart Assoc 2014 0.79
70 Stimulation of adenosine A2b receptors blocks apoptosis in the non-infarcted myocardium even when administered after the onset of infarction. Mol Cell Biochem 2009 0.79
71 Mechanisms of myocardial remodeling: ramiprilat blocks the expressional upregulation of protein kinase C-epsilon in the surviving myocardium early after infarction. J Cardiovasc Pharmacol 2003 0.78
72 A novel activation process of protein kinase C in the remote, non-ischemic area of an infarcted heart is mediated by angiotensin-AT1 receptors. J Mol Cell Cardiol 2003 0.78
73 Comparative morphometric and immunohistological assessment of the development of restenosis after arterial injury and a cholesterol-rich diet in apolipoprotein E -/-mice and C57BL/6 control mice. Coron Artery Dis 2005 0.78
74 Regulation of the isozymes of protein kinase C in the surviving rat myocardium after myocardial infarction: distinct modulation for PKC-alpha and for PKC-delta. Basic Res Cardiol 2002 0.77
75 From bench to bedside: chromogranin B-a promising novel biomarker in heart failure. Congest Heart Fail 2011 0.77
76 [Which kinds of distress do partners or spouses of cardiac arrhythmias patients exhibit?]. Z Psychosom Med Psychother 2006 0.77
77 Transregulation of the alpha2-adrenergic signal transduction pathway by chronic beta-blockade: a novel mechanism for decreased platelet aggregation in patients. J Cardiovasc Pharmacol 2005 0.77
78 Atrial fibrillation is associated with high levels of monocyte-platelet-aggregates and increased CD11b expression in patients with aortic stenosis. Thromb Haemost 2016 0.77
79 SPIRIT Women, evaluation of the safety and efficacy of the XIENCE V everolimus-eluting stent system in female patients: referral time for coronary intervention and 2-year clinical outcomes. EuroIntervention 2012 0.77
80 Pharmacological postconditioning by bolus injection of phosphodiesterase-5 inhibitors vardenafil and sildenafil. Mol Cell Biochem 2013 0.76
81 Valvular heart disease in Parkinson's disease patients treated with dopamine agonists: a reader-blinded monocenter echocardiography study. Mov Disord 2007 0.76
82 Multicentre evaluation of a second generation point-of-care assay with an extended range for the determination of N-terminal pro-brain natriuretic peptide. Clin Lab 2012 0.76
83 Guillain-Barré syndrome and catecholamine therapy. A potential risk for developing takotsubo cardiomyopathy? Int J Cardiol 2012 0.75
84 Chromogranin B in calpain-mediated hypertrophic signaling--the chicken, the egg, or even both...? Circ Res 2011 0.75
85 Letter by Ibrahim et al regarding article "Circulating endothelial progenitor cells do not contribute to plaque endothelium in murine atherosclerosis". Circulation 2010 0.75
86 A prospective, randomized trial of continuous lateral rotation ("kinetic therapy") in patients with cardiogenic shock. Clin Res Cardiol 2012 0.75
87 Chronic diarrhea as the initial clinical manifestation of light-chain amyloidosis with cardiac involvement despite negative duodenal and rectal biopsies. Exp Clin Cardiol 2013 0.75
88 Comparison of external and intravascular cooling to induce hypothermia in patients after CPR. Ger Med Sci 2006 0.75
89 Stored red blood cells impair vascular function in vivo. Transfusion 2014 0.75
90 Dual mechanism of autoregulation of protein kinase C in myocardial ischemia. Mol Cell Biochem 2006 0.75
91 'Crystal' in the heart. Kardiol Pol 2013 0.75
92 A rare type of ventricular oversensing in ICD therapy--inappropriate ICD shock delivery due to triple counting. Pacing Clin Electrophysiol 2009 0.75
93 Kinetic therapy reduces complications and shortens hospital stay in patients with cardiogenic shock - a retrospective analysis. Eur J Cardiovasc Nurs 2006 0.75
94 The calcium channel blocker felodipine attenuates the positive hemodynamic effects of the beta-blocker metoprolol in severe dilated cardiomyopathy--a prospective, randomized, double-blind and placebo-controlled study with invasive hemodynamic assessment. Int J Cardiol 2008 0.75
95 Primary aortic sarcoma with multiple metastatic sites. Eur Heart J 2012 0.75
96 The endothelial nitric oxide synthase cofactor tetrahydrobiopterin shields the remote myocardium from apoptosis after experimental myocardial infarction in vivo. Kardiol Pol 2017 0.75
97 ELMSTREET (Esophageal Lesions during MitraClip® uSing TRansEsophagelEchocardiography-Trial). EuroIntervention 2017 0.75
98 Chelerythrine treatment influences the balance of pro- and anti-apoptotic signaling pathways in the remote myocardium after infarction. Mol Cell Biochem 2007 0.75
99 Influence of adenosine on ventricular function measurements as part of a comprehensive stress perfusion magnetic resonance imaging study. Acta Radiol 2011 0.75
100 Acute coronary syndrome and single coronary artery ostium. Kardiol Pol 2014 0.75
101 3-T magnetic resonance for determination of aortic valve area: a comparison to echocardiography. Scand Cardiovasc J 2014 0.75
102 Transapical septal occluder for paravalvular leakage of the mitral valve: a novel method for interventional treatment in high-risk patients. Clin Res Cardiol 2011 0.75
103 Right ventricular dilatation predicts survival after mitral valve repair in patients with impaired left ventricular systolic function. Eur J Echocardiogr 2008 0.75
104 Influence of the trigger technique on ventricular function measurements using 3-Tesla magnetic resonance imaging: comparison of ECG versus pulse wave triggering. Acta Radiol 2011 0.75
105 Three-Dimensional Left Ventricular Torsion in Patients With Dilated Cardiomyopathy - A Marker of Disease Severity. Circ J 2017 0.75
106 Non-compaction cardiomyopathy with low-gradient aortic valve stenosis. Eur Heart J 2008 0.75
107 Intracoronary radiotherapy with a (188)rhenium liquid-filled PTCA balloon system in in-stent restenosis: acute and long-term angiographic results, as well as 1-year clinical follow-up. Int J Cardiol 2004 0.75
108 Inhibition of anti-apoptotic signals by Wortmannin induces apoptosis in the remote myocardium after LAD ligation: evidence for a protein kinase C-δ-dependent pathway. Mol Cell Biochem 2012 0.75
109 [Severe progression of coronary heart disease in a patient with elevated lipoprotein (a) level in spite of optimal LDL-C decrease]. Herz 2007 0.75
110 Images in emergency medicine. Perforation of the right ventricle and lung parenchyma by a pacemaker lead. Ann Emerg Med 2007 0.75
111 Images in cardiovascular medicine. Cardiomyopathy resulting from primary hyperoxaluria type II. Circulation 2006 0.75
112 Beans in the pericardium. Lancet 2009 0.75
113 Intracoronary radiotherapy with a 188Rhenium liquid-filled angioplasty balloon system in in-stent restenosis: a single-center, prospective, randomized, placebo-controlled, double-blind evaluation. Coron Artery Dis 2006 0.75
114 Acute dysphagia after myocardial infarction: an unusual complication of anticoagulation therapy. Kardiol Pol 2014 0.75
115 Recording atrial monophasic action potentials using standard pacemaker leads: an alternative way to study electrophysiology properties of the human atrium in vivo? Pacing Clin Electrophysiol 2004 0.75
116 Survived sudden cardiac death in a young marathon runner: cardiac ischemic event attributed to an interarterial course of the right coronary artery. Circulation 2013 0.75
117 Images in clinical medicine. Impending rupture of the myocardial wall. N Engl J Med 2003 0.75
118 Pre-hospital discharge testing of defibrillator without anesthesia: effects on psychological symptoms during clinical follow-up. Psychosom Med 2013 0.75
119 A novel interventional method for treating femoral pseudoaneurysms- results from a monocentric experience. EuroIntervention 2017 0.75
120 How should I treat a partially released JenaValve™ in the ascending aorta, whose feelers cannot be positioned inside the corresponding aortic sinus? EuroIntervention 2015 0.75
121 Time-resolved magnetic resonance imaging of contrast kinetics to identify severe tricuspid valve regurgitation. Acta Cardiol 2013 0.75